Prostatic adenocarcinoma following androgen deprivation therapy: the new difficulty in histologic interpretation.

Anatomic pathology (Chicago, Ill. : annual)

Volumn 3, Issue , 1998, Pages 1-16

  Bostwick, D G ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; CHOLESTENONE 5ALPHA REDUCTASE; ENZYME INHIBITOR; FINASTERIDE; OXIDOREDUCTASE;

ADENOCARCINOMA; DIFFERENTIAL DIAGNOSIS; DRUG ANTAGONISM; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; REVIEW;

ADENOCARCINOMA; ANDROGEN ANTAGONISTS; CHOLESTENONE 5 ALPHA-REDUCTASE; DIAGNOSIS, DIFFERENTIAL; ENZYME INHIBITORS; FINASTERIDE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; OXIDOREDUCTASES; PROSTATIC NEOPLASMS;

EID: 0032234367     PISSN: 10565884     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (84)